Avanos Medical, Inc. (NYSE: AVNS), a Georgia-based medical technology company involved in delivering medical device solutions, announced on Monday that it has named Indrani Franchini as a new independent member of the Avanos board of directors.
Franchini has worked as executive vice president and chief legal officer at Alnylam Pharmaceuticals, executive vice president and chief compliance officer at Alexion Pharmaceuticals, Inc, and has served in various roles in legal and compliance at Hess Corporation. She has also served for around 10 years at Pfizer in various positions, including supporting the global pharmaceutical business. She has also practiced law at Milbank LLP, where she served for six years working in the firm's New York and Tokyo offices.
Gary Blackford, Avanos board chair, said, 'We are excited to welcome Indrani Franchini to the Avanos board. Her experience with a broad range of global companies will be invaluable to Avanos as we pursue our vision of getting patients back to the things that matter.'
Johnson & Johnson agrees acquisition of V-Wave
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott
OncoBeta expands Rhenium-SCT (Skin Cancer Therapy) treatment services in Italy
Labcorp's PGDx elio plasma focus Dx receives US FDA De Novo marketing authorisation
Verici Dx announces completion of Thermo Fisher Scientific licensing agreement
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center